• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用水疱性口炎病毒假型和定点突变技术鉴定汉坦病毒表面糖蛋白 Gn 和 Gc 上的 MAb 中和表位。

Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis.

机构信息

1​Department of Virology, University of Helsinki, Medicum, Helsinki, Finland.

2​Department of Medical Biochemistry and Microbiology, Microbiology-Immunology, Uppsala University, Uppsala, Sweden.

出版信息

J Gen Virol. 2019 Feb;100(2):145-155. doi: 10.1099/jgv.0.001202. Epub 2019 Jan 9.

DOI:10.1099/jgv.0.001202
PMID:30624178
Abstract

Earlier four monoclonal antibodies (MAbs) against surface glycoproteins Gn and Gc of puumala virus (PUUV, genus Orthohantavirus, family Hantaviridae, order Bunyavirales) were generated and for three MAbs with neutralizing capacity the localization of binding epitopes was predicted using pepscan and phage-display techniques. In this work, we produced vesicular stomatitis virus (VSV) particles pseudotyped with the Gn and Gc glycoproteins of PUUV and applied site-directed mutagenesis to dissect the structure of neutralizing epitopes. Replacement of cysteine amino acid (aa) residues with alanines resulted in pseudotype particles with diminished (16 to 18 %) neut-titres; double Cys→Ala mutants, as well as mutants with bulky aromatic and charged residues replaced with alanines, have shown even stronger reduction in neut-titres (from 25 % to the escape phenotype). In silico modelling of the neut-epitopes supported the hypothesis that these critical residues are located on the surface of viral glycoprotein molecules and thus can be recognized by the antibodies indeed. A similar pattern was observed in experiments with mutant pseudotypes and sera collected from patients suggesting that these neut-epitopes are utilized in a course of human PUUV infection. These data will help understanding the mechanisms of hantavirus neutralization and assist construction of vaccine candidates.

摘要

先前已经产生了针对普马拉病毒(PUUV,正呼肠孤病毒科,汉坦病毒科,布尼亚病毒目)表面糖蛋白 Gn 和 Gc 的四种单克隆抗体(MAb),对于三种具有中和能力的 MAb,使用 pepscan 和噬菌体展示技术预测了结合表位的定位。在这项工作中,我们生产了假型为普马拉病毒 Gn 和 Gc 糖蛋白的水疱性口炎病毒(VSV)颗粒,并应用定点突变技术来剖析中和表位的结构。用丙氨酸替换半胱氨酸氨基酸(aa)残基导致假型颗粒的中和效价降低(16%至 18%);双 Cys→Ala 突变体,以及用芳香族和带电荷的大残基替换的突变体,甚至显示出更强的中和效价降低(从 25%到逃逸表型)。中和表位的计算机建模支持了这样一种假设,即这些关键残基位于病毒糖蛋白分子的表面,因此确实可以被抗体识别。在突变假型和从患者中收集的血清的实验中观察到了类似的模式,表明这些中和表位在人类 PUUV 感染过程中被利用。这些数据将有助于理解汉坦病毒中和的机制,并有助于构建疫苗候选物。

相似文献

1
Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis.利用水疱性口炎病毒假型和定点突变技术鉴定汉坦病毒表面糖蛋白 Gn 和 Gc 上的 MAb 中和表位。
J Gen Virol. 2019 Feb;100(2):145-155. doi: 10.1099/jgv.0.001202. Epub 2019 Jan 9.
2
Validation of an antigenic site targeted by monoclonal antibodies against Puumala virus.针对普马拉病毒的单克隆抗体靶向抗原表位的验证。
J Gen Virol. 2023 Oct;104(10). doi: 10.1099/jgv.0.001901.
3
Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.鉴定与水疱性口炎病毒印第安纳株 G 蛋白及其他水疱病毒 G 蛋白的抗体相互作用。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.00900-18. Print 2018 Dec 1.
4
Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.针对安第斯病毒糖蛋白刺突复合物的 Gn 和 Gc 的中和单克隆抗体可在临床前仓鼠模型中预防病毒挑战。
mBio. 2020 Mar 24;11(2):e00028-20. doi: 10.1128/mBio.00028-20.
5
Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.两个旧世界汉坦病毒糖蛋白中的突变赋予了高传染性重组水疱性口炎病毒载体的产生。
mBio. 2019 Jan 8;10(1):e02372-18. doi: 10.1128/mBio.02372-18.
6
Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.通过痘苗病毒载体表达的两种水疱性口炎病毒糖蛋白基因的缺失突变体和嵌合体进行表位作图。
Virology. 1989 Jun;170(2):392-407. doi: 10.1016/0042-6822(89)90430-3.
7
Immunoglobulin A responses to Puumala hantavirus.针对普马拉汉坦病毒的免疫球蛋白A反应。
J Gen Virol. 2000 Jun;81(Pt 6):1453-61. doi: 10.1099/0022-1317-81-6-1453.
8
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.针对水疱性口炎病毒(新泽西血清型)糖蛋白的单克隆抗体:一种抗原表位初步定位的方法。
Virology. 1987 Dec;161(2):533-40. doi: 10.1016/0042-6822(87)90148-6.
9
Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus.对人源单克隆抗体AH100抗汉坦病毒中和机制的分子洞察。
J Virol. 2024 Aug 20;98(8):e0088324. doi: 10.1128/jvi.00883-24. Epub 2024 Jul 30.
10
Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.鉴定严重急性呼吸综合征冠状病毒刺突糖蛋白上负责中和抗体及DC-SIGN结合的表位。
J Virol. 2006 Nov;80(21):10315-24. doi: 10.1128/JVI.01138-06.

引用本文的文献

1
The Adaptive Immune Response against .针对 的适应性免疫反应。
Viruses. 2024 Mar 21;16(3):483. doi: 10.3390/v16030483.
2
Pseudotyped Viruses for Orthohantavirus.用于正汉坦病毒的假型病毒
Adv Exp Med Biol. 2023;1407:229-252. doi: 10.1007/978-981-99-0113-5_12.
3
T-cell epitope-based vaccine designing against Orthohantavirus: a causative agent of deadly cardio-pulmonary disease.基于T细胞表位的抗正汉坦病毒疫苗设计:一种致命心肺疾病的病原体
Netw Model Anal Health Inform Bioinform. 2022;11(1):2. doi: 10.1007/s13721-021-00339-x. Epub 2021 Dec 7.
4
Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein.汉坦病毒融合糖蛋白抗体介导靶向作用的分子基础。
Elife. 2020 Dec 22;9:e58242. doi: 10.7554/eLife.58242.
5
Humoral Immunity to Hantavirus Infection.汉坦病毒感染的体液免疫。
mSphere. 2020 Jul 15;5(4):e00482-20. doi: 10.1128/mSphere.00482-20.
6
Hantavirus entry: Perspectives and recent advances.汉坦病毒进入机制:观点与最新进展。
Adv Virus Res. 2019;104:185-224. doi: 10.1016/bs.aivir.2019.07.002. Epub 2019 Aug 7.